Evaluating the changes in outcome and serum metabolic biochemical parameters after oral Simvastatin administration in patients with poly cystic ovary syndrome undergoing IVF
Not Applicable
- Conditions
- Poly Cystic Ovarian Syndrom.Sclerocystic ovary syndrome
- Registration Number
- IRCT2012110811408N1
- Lead Sponsor
- Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences and Health ser
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
inclusion criteria: All patients in reproductive age with pcos that refer to infertility clinic of fatemieh hospital of Hamadan, that agreed to participate in the study and complete the informed consent, and without history of endocrine disease, Recent use of lipid-lowering drugs and statins.
exclusion criteria: don't referring After getting treatment, arbitrary discontinuation of treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HDL. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;LDL. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;TG. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;Testestroon. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.;GTT. Timepoint: before of study and the fourth and eighth weeks. Method of measurement: with Biochemical laboratory techniques and in mg per deciliter.
- Secondary Outcome Measures
Name Time Method